News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy
Photo: The Lancet Haematology/Twitter
May 18, 2023, 14:56

Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy

NEW: Inotuzumab ozogamicin with or without blinatumomab added to low-intensity chemotherapy showed promising activity in terms of PFS in older patients with B-cell ALL: results of a phase 2 trial

Source: The Lancet Haematology/Twitter

blinatumomab Inotuzumab ozogamicin phase 2 trial The Lancet Haematolog
Special Coverage
Immune Oncology
Aug 2, 2025, 17:17
Real-World Study Confirms Nivolumab Plus Cabozantinib Improves Survival in Metastatic RCC
Science
Aug 2, 2025, 16:59
Myeloma Paper of the Day, August 2nd, Suggested by Robert Orlowski
Blog
Aug 2, 2025, 15:35
Dinesh Pendharkar: Empowering the Last Mile
Insight
Aug 2, 2025, 15:10
Veronica R Bravo: The Role of Off-pore Nucleoporins in Prostate Cancer Progression and Immune Evasion
Blog
Aug 2, 2025, 14:31
Estela Rodriguez: Dr Richard Kim on Translating Recent ASCO Colorectal Abstracts into Practice
Oncolibrary
Aug 2, 2025, 14:29
CAR T-Cell Therapy: A New Frontier in Cancer Immunotherapy
Blog
Aug 2, 2025, 14:09
Lisa Lacasse: We Applaud Bipartisan Commitment to Cancer Research
Insight
Aug 2, 2025, 13:59
Highlights From Bladder Cancer Advocacy Network Think Tank 2025 by Shilpa Gupta
Blog
Aug 2, 2025, 13:43
Al-Ola A Abdallah: Barry Paul on CAR T-cell Therapies in Multiple Myeloma
Societies
Aug 2, 2025, 13:34
Senate Appropriations Committee Approves $400 Million Increase NIH Funding - ASH
Blog
Aug 2, 2025, 13:24
Jean-Yves Blay: Management and Outcome of 11,132 Patients with Liposarcoma
Oncolibrary
Aug 2, 2025, 13:24
Brain Tumor Chemotherapy Success Rate: What Patients Need to Know in 2025